Kaloba® is the best selling drug in Germany for the treatment of viral respiratory tract infections including bronchitis, sinusitis, tonsillopharyngitis & common cold. The main ingredient is the Pelargonium plant, used by ancient Zulus for treating chest pain, respiratory infections and tubercolosis.

The modern Kaloba® products that we have now are developed by Dr. Willmar Schwabe into a rational phyto-pharmaceutical drug. The Pelargonium plants are cultivated in Dr. Willmar Schwabe owned plantations under Good Agricultural Practice (GAP), the extraction of active ingredients and manufacturing processes of Kaloba strictly follow the Good Manufacturing Practice (GMP) with quality control under Good Laboratory Practice (GLP).

Kaloba® is available in more than 30 countries worldwide.

Kaloba® has a unique triple mode of action

a) Activates Defence Mechanisms Against Viral Attack thereby treating the root cause of respiratory tract infections

b) Moderate anti-bacterial properties prevent secondary infections

c) Exhibits Expectorant Properties help to provide symptomatic relief

Kaloba® is a modern phyto-pharmaceutical drug that is indicated as
“The 1st line therapy for treatment of viral respiratory tract infections”

Kaloba® contains the proprietary Pelargonium sidoides extract EPs® 7630. Unlike other respiratory tract infection medications, Kaloba® offers more than symptomatic relief, it treats the root cause of respiratory tract infections thereby shortening the duration of the illnesses.

Kaloba’s therapeutic Indications are:

Acute Bronchitis,
Acute Sinusitis and
Common Cold (Rhinopharyngitis)

For more information, please contact enquiry@ahcg.com.my